Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
149
datasets available to search
ShareScore release 0.9.0
Dataset results
149 results for “IGEs”
Comparison of conventional IgE assay and measurement of specific IgE to hemocyanin for the diagnosis of adult crab allergy (Running tile: Utility of crab extracts and hemocyanin in diagnosing crab allergy)
<p><span>Summary: </span></p> <p><span><span> </span>Specific IgE to hemocyanin was elevated in crab-allergic as compared to crab-tolerant patients.</span></p> <p><span><span> </span>The combination of specific IgE to hemocyanin and conventional IgE assays improved specificity.</span></p>
Comparison of conventional IgE assay and measurement of specific IgE to hemocyanin for the diagnosis of adult crab allergy (Running tile: Utility of crab extracts and hemocyanin in diagnosing crab allergy)
<p>Summary:</p> <p> Specific IgE to hemocyanin was elevated in crab-allergic as compared to crab-tolerant patients.</p> <p> The combination of specific IgE to hemocyanin and conventional IgE assays improved specificity.</p>
Additional information to Research Letter "Immunogenicity of Cephalosporin Components in Non-IgE Mediated Cephalosporin Allergy"
<p>The file contains the following information:</p><p><strong>Additional information</strong></p><p><strong>Description</strong></p><p><strong>Page</strong></p><p>Materials and Methods</p><p>Study materials, syntheses of degradation products and enzyme-linked immunospot assay used in the study</p><p>1-3</p><p>Table 1</p><p>In vitro reactivity to different components of ceftriaxone degradation products in patients with positive ELISpot to ceftriaxone or cephalosporine with similar R1 side chain to ceftriaxone (N=21), categorized by underlying diseases and drug allergic phenotypes</p><p>4</p><p>Table 2</p><p>Clinical characteristics of patients with a confirmed non-IgE mediated hypersensitivity reaction to ceftriaxone or cephalosporin with a similar R1 side chain to ceftriaxone</p><p>5-6</p><p>Table 3</p><p>Frequencies of IFN-γ releasing cells and proportions of positive IFN-γ ELISpot assay upon stimulation with the suspected culprit drugs and different cephalosporins in patients with a history of non-IgE mediated reaction to ceftriaxone or cephalosporins with a similar R1 side chain (N= 21)</p><p>7-9</p><p>Figure captions and Figure legends</p><p> </p><p>Figure captions and figure legends for figures 1, 2, 3A, 3B, and 4.</p><p> </p><p>10</p><p> </p><p>Figure 1</p><p> </p><p>Mass spectrum results of the synthesized octalysine-ceftriaxone conjugates</p><p> </p><p> Figure 2</p><p>Chemical structures of cephalosporin components in this study</p><p> </p><p>Fig 3</p><p>Representative figures of IFN-γ releasing cells after stimulating PBMCs with different cephalosporins and their components, as demonstrated by ELISpot assay in two patients with a history of ceftriaxone-induced DRESS. Figure 3A shows the results for a single cephalosporin reactor, and Figure 3B shows the results for a multiple cephalosporin reactor.</p><p> </p><p>Fig 4</p><p>The frequencies of IFN-γ releasing cells and proportions of positive IFN-γ ELISpot assay upon stimulation with the suspected culprit drugs, other cephalosporins, and different components in patients with a history of non-IgE mediated reaction to ceftriaxone or cephalosporins with a similar R1 side chain (N= 21)</p><p> </p><p> </p>
shelmscahan/IGE_HelmsCahan_2019: HelmsCahan_IGE_2019
<p>Data repository for Helms Cahan et al. IGE 2019, "Residual survival and local dispersal drive reinfestation by Triatoma dimidiata following insecticide application in Guatemala."</p>
Effect of Ranitidine on Hyper-IgE Recurrent Infection (Job's) Syndrome
ClinicalTrials.gov study NCT00527878. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial
ClinicalTrials.gov study NCT01781637. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase I Study of MOv18 IgE
ClinicalTrials.gov study NCT02546921. IPD Sharing: NO. Countries: 1. Publications: 2.
Inner-City Anti-IgE Therapy for Asthma
ClinicalTrials.gov study NCT00377572. IPD Sharing: YES. Countries: 1. Publications: 6.
The Effects of Omalizumab (Anti-IgE) on the Late-phase Response to Nasal Allergen Challenge
ClinicalTrials.gov study NCT01003301. IPD Sharing: Not stated. Countries: 1. Publications: 30.
Efficacy and Safety of Viaskin Milk in Children With IgE-Mediated Cow's Milk Allergy
ClinicalTrials.gov study NCT02223182. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Efficacy and Safety of Viaskin Peanut in Children With Immunoglobulin E (IgE)-Mediated Peanut Allergy
ClinicalTrials.gov study NCT02636699. IPD Sharing: Not stated. Countries: 5. Publications: 4.
Role of Immunoglobulin E (IgE) Bearing Cells in Chronic Idiopathic Urticaria (CIU)
ClinicalTrials.gov study NCT03111628. IPD Sharing: NO. Countries: 1. Publications: 2.
Effect of Omalizumab on Expression of IgE Receptors in Adults With Severe, Inadequately Controlled Allergic Asthma
ClinicalTrials.gov study NCT00454051. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Subjects With IgE >= 30 IU/mL
ClinicalTrials.gov study NCT01544348. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety, Tolerability, and Immunogenicity of One Dose of NDV 3A Vaccine in People With STAT3-Mutated Hyper-IgE Syndrome
ClinicalTrials.gov study NCT02996448. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis
ClinicalTrials.gov study NCT03835767. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Protection From Food Induced Anaphylaxis by Reducing the Serum Level of Specific IgE (Protana).
ClinicalTrials.gov study NCT03964051. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Extracorporeal SPecific IgE Removal From the Plasma of Allergic Asthma Patients (ESPIRA-study)
ClinicalTrials.gov study NCT02096237. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Undetectable IgE as a Sentinel Biomarker for Humoral Immunodeficiency
ClinicalTrials.gov study NCT03968211. IPD Sharing: YES. Countries: 1. Publications: 1.
NAET Screening for Food Allergy, Sensitivity and Intolerances Using IgE-Specific Antigen Test and NST- NAET®
ClinicalTrials.gov study NCT00275795. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.